SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

NCT00180479 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1002

Enrollment

INDUSTRY

Sponsor class

Conditions

Stents
Coronary Artery Disease
Total Coronary Occlusion
Coronary Artery Restenosis
Stent Thrombosis
Vascular Disease
Myocardial Ischemia
Coronary Artery Stenosis

Interventions

DEVICE: XIENCE V® Everolimus Eluting Coronary Stent
DEVICE: TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent

Sponsor

Abbott Medical Devices